×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AMLX – amylyx pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AMLX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/24
10:00 am
amlx
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Stockholders to Learn More About the Investigation
Low
Report
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Stockholders to Learn More About the Investigation
12/22
10:00 am
amlx
Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Investors to Inquire about Securities Investigation
Low
Report
Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Investors to Inquire about Securities Investigation
12/18
10:00 am
amlx
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Investors to Reach Out
Medium
Report
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Investors to Reach Out
12/15
10:00 am
amlx
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out
Low
Report
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out
12/11
02:00 pm
amlx
Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Connect
Low
Report
Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Connect
12/5
08:01 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
12/4
07:31 am
amlx
Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia [Yahoo! Finance]
12/4
07:30 am
amlx
Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia
Low
Report
Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
07:00 am
amlx
amylyx pharmaceuticals, inc.
MISS
Report
9.0%
amylyx pharmaceuticals, inc.
8/8/2024
07:00 am
amlx
amylyx pharmaceuticals, inc.
MISS
Report
-7.2%
amylyx pharmaceuticals, inc.
5/9/2024
07:00 am
amlx
amylyx pharmaceuticals, inc.
MISS
Report
-1.6%
amylyx pharmaceuticals, inc.
2/22/2024
07:00 am
amlx
amylyx pharmaceuticals, inc.
MISS
Report
23.4%
amylyx pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/3
05:22 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Dec 02 Filed by: Bedrosian Camille L
Low
Report
Form 4 Amylyx Pharmaceuticals, For: Dec 02 Filed by: Bedrosian Camille L
11/12
01:23 pm
amlx
Form SC 13G/A Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
11/7
08:23 am
amlx
Form 10-Q Amylyx Pharmaceuticals, For: Sep 30
High
Report
Form 10-Q Amylyx Pharmaceuticals, For: Sep 30
11/7
07:08 am
amlx
Form 8-K Amylyx Pharmaceuticals, For: Nov 07
Medium
Report
Form 8-K Amylyx Pharmaceuticals, For: Nov 07
11/6
07:25 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Nov 04 Filed by: Klee Justin B.
Medium
Report
Form 4 Amylyx Pharmaceuticals, For: Nov 04 Filed by: Klee Justin B.
11/4
10:57 am
amlx
Form SC 13G Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
10/25
05:38 pm
amlx
Form SC 13G Amylyx Pharmaceuticals, Filed by: PERCEPTIVE ADVISORS LLC
Low
Report
Form SC 13G Amylyx Pharmaceuticals, Filed by: PERCEPTIVE ADVISORS LLC
10/17
09:13 am
amlx
Form 8-K Amylyx Pharmaceuticals, For: Oct 17
Medium
Report
Form 8-K Amylyx Pharmaceuticals, For: Oct 17
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: